OTC · SSSGY
Healthcare · Medical - Instruments & Supplies
$43.93
Up+$0.00 (+0.00%)
Updated Nov 13, 2026, 11:17 AM
SID Score
4.7/10
Composite research score
Smart Money
46/100
Neutral
Price performance · SSSGY
1M range · 0 trading sessions · Daily adjusted prices
SSSGY does not have enough price history for the selected period.
Data unavailable
The requested market data was not found.
The latest Smart Investors Daily articles mentioning SSSGY.
Company
Market Activity
Research & News
SSSGY research
Company profile and research snapshot.
SARTORIUS AG UNSP/ADR
Visit company websiteConsensus and target data currently published for this company.
| Date | Firm | Rating | Target |
|---|---|---|---|
| Jul 27, 2026 | JEFFERIES | Buy | — |
| Jul 27, 2026 | ROTHSCHILD & CO REDBURN | Buy | — |
| Jul 14, 2026 | ROTHSCHILD & CO REDBURN | Buy | — |
| Jul 13, 2026 | ROTHSCHILD & CO REDBURN | Buy | — |
| Apr 23, 2026 | JEFFERIES | Buy | — |
No generated briefing is available yet.
Yahoo · Nov 7, 2026
We have just published our list of the 10 Activist Target Stocks with High Cash and Low Valuations, with Bio-Rad Laboratories ranked 8th on the list. Bio-Rad Laboratories, Inc. (NYSE:BIO) is an interesting activist-investor target as it combines a substantial liquid asset position and an underperforming core business that could benefit from operational restructuring. While […]
Yahoo · Oct 27, 2026
Is BIO a good stock to buy? We came across a bullish thesis on Bio-Rad Laboratories, Inc. on One Idea Per Day’s Substack by Paul. The thesis was published on July 21st, when the stock was trading at $281.11, and BIO has gained 32.48% since then. The rise appears to reflect investor hopes that activist investor Elliott […]
Yahoo · Oct 26, 2026
Sartorius (XTRA:SRT3) has put several big pieces on the table at once, reporting higher third quarter and nine month sales and net income, reaffirming 2026 guidance, and outlining a segment overhaul and executive reshuffle. Investors have reacted quickly to the fresh guidance and restructuring plan, with Sartorius delivering a 2.73% 1 day share price return and a 30.17% 90 day share price return, while the 21.65% 1 year total shareholder return contrasts with a 48.30% total shareholder return...
SeekingAlpha · Oct 26, 2026
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
The latest Smart Investors Daily articles mentioning SSSGY.
